---
title: Stargardt disease prognosis and management
description: "Stargardt disease is an inherited macular dystrophy that typically causes progressive central vision loss while peripheral vision remains relatively preserved. ## Prognosis The rate of decline varies with the underlying genetic mutation and age of onset. - Many patients reach…"
url: "https://bluefinvision.com/knowledge-base/topics/conditions-diseases/stargardt-disease-prognosis-and-management/"
updated: "2025-12-15"
category: "Conditions & Diseases"
---

# Stargardt disease prognosis and management

Stargardt disease is an inherited macular dystrophy that typically causes progressive central vision loss while peripheral vision remains relatively preserved.

## Prognosis

The rate of decline varies with the underlying genetic mutation and age of onset.

- Many patients reach legal driving thresholds in adolescence or early adulthood, though some progress more slowly.
- Peripheral fields and mobility are usually maintained, allowing good orientation in familiar environments.
- There is currently no widely available cure, but several gene and pharmacologic therapies are under investigation.
- UV and blue‑light protection and avoidance of smoking are generally recommended.

## Management

Care focuses on maximising remaining vision and supporting independence.

- Low‑vision aids, electronic magnifiers, and adaptive technology can greatly enhance reading and education.
- Regular monitoring with OCT and fundus imaging tracks structural change and helps identify eligibility for clinical trials.
- Genetic counselling informs family planning and access to emerging therapies.
- Registration with sight‑loss services can provide practical and psychological support.